S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Crews turn sights to removing debris from ship's deck in Baltimore bridge collapse cleanup
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Crews turn sights to removing debris from ship's deck in Baltimore bridge collapse cleanup
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Crews turn sights to removing debris from ship's deck in Baltimore bridge collapse cleanup
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
How major US stock indexes fared Friday, 4/19/2024
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Crews turn sights to removing debris from ship's deck in Baltimore bridge collapse cleanup
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers

Genpact (G) Competitors

$31.59
+0.70 (+2.27%)
(As of 04/19/2024 ET)

G vs. FCN, EXPO, ICFI, HURN, BAH, FCFS, FOUR, SPXC, RCM, and KVYO

Should you be buying Genpact stock or one of its competitors? The main competitors of Genpact include FTI Consulting (FCN), Exponent (EXPO), ICF International (ICFI), Huron Consulting Group (HURN), Booz Allen Hamilton (BAH), FirstCash (FCFS), Shift4 Payments (FOUR), SPX Technologies (SPXC), R1 RCM (RCM), and Klaviyo (KVYO). These companies are all part of the "business services" sector.

Genpact vs.

FTI Consulting (NYSE:FCN) and Genpact (NYSE:G) are both mid-cap industrials companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, dividends, community ranking, risk, analyst recommendations, institutional ownership, valuation and earnings.

FTI Consulting presently has a consensus target price of $255.00, indicating a potential upside of 20.71%. Genpact has a consensus target price of $40.11, indicating a potential upside of 26.97%. Given FTI Consulting's higher probable upside, analysts clearly believe Genpact is more favorable than FTI Consulting.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
FTI Consulting
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
Genpact
1 Sell rating(s)
5 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

In the previous week, Genpact had 2 more articles in the media than FTI Consulting. MarketBeat recorded 6 mentions for Genpact and 4 mentions for FTI Consulting. Genpact's average media sentiment score of 0.60 beat FTI Consulting's score of 0.54 indicating that FTI Consulting is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
FTI Consulting
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Genpact
3 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Genpact has higher revenue and earnings than FTI Consulting. Genpact is trading at a lower price-to-earnings ratio than FTI Consulting, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
FTI Consulting$3.49B2.15$274.89M$7.7127.40
Genpact$4.48B1.27$631.26M$3.439.21

Genpact has a net margin of 14.10% compared to Genpact's net margin of 7.88%. FTI Consulting's return on equity of 23.19% beat Genpact's return on equity.

Company Net Margins Return on Equity Return on Assets
FTI Consulting7.88% 14.94% 8.46%
Genpact 14.10%23.19%10.23%

FTI Consulting has a beta of 0.11, indicating that its share price is 89% less volatile than the S&P 500. Comparatively, Genpact has a beta of 1.07, indicating that its share price is 7% more volatile than the S&P 500.

99.4% of FTI Consulting shares are held by institutional investors. Comparatively, 96.0% of Genpact shares are held by institutional investors. 3.3% of FTI Consulting shares are held by insiders. Comparatively, 2.8% of Genpact shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Genpact received 259 more outperform votes than FTI Consulting when rated by MarketBeat users. Likewise, 68.54% of users gave Genpact an outperform vote while only 54.39% of users gave FTI Consulting an outperform vote.

CompanyUnderperformOutperform
FTI ConsultingOutperform Votes
229
54.39%
Underperform Votes
192
45.61%
GenpactOutperform Votes
488
68.54%
Underperform Votes
224
31.46%

Summary

Genpact beats FTI Consulting on 10 of the 18 factors compared between the two stocks.

Get Genpact News Delivered to You Automatically

Sign up to receive the latest news and ratings for G and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding G and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

G vs. The Competition

MetricGenpactManagement consulting services IndustryBusiness SectorNYSE Exchange
Market Cap$5.70B$2.61B$6.57B$17.16B
Dividend Yield1.97%3.46%3.01%3.62%
P/E Ratio9.2111.0515.1922.32
Price / Sales1.271.582,677.009.70
Price / Cash9.8818.9025.9817.06
Price / Book2.553.104.484.85
Net Income$631.26M$130.14M$133.14M$970.56M
7 Day Performance1.22%-3.03%-3.01%-1.76%
1 Month Performance-5.81%-8.86%-5.69%-3.82%
1 Year Performance-29.44%3.11%7.00%100.03%

Genpact Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FCN
FTI Consulting
4.4571 of 5 stars
$207.78
+0.0%
$255.00
+22.7%
+6.8%$7.38B$3.49B26.957,990Upcoming Earnings
Analyst Downgrade
News Coverage
EXPO
Exponent
3.0355 of 5 stars
$81.12
+0.9%
$97.00
+19.6%
-18.9%$4.10B$536.77M41.601,320Upcoming Earnings
ICFI
ICF International
3.4271 of 5 stars
$143.89
-1.5%
$162.75
+13.1%
+27.5%$2.69B$1.96B33.089,000Positive News
HURN
Huron Consulting Group
4.6382 of 5 stars
$94.92
+0.5%
$129.33
+36.3%
+10.6%$1.75B$1.40B29.666,480News Coverage
BAH
Booz Allen Hamilton
4.5081 of 5 stars
$143.53
-2.6%
$139.56
-2.8%
+44.6%$18.62B$9.26B46.3031,900Positive News
FCFS
FirstCash
4.3395 of 5 stars
$125.93
+0.2%
$116.83
-7.2%
+33.6%$5.68B$3.15B26.2419,000Upcoming Earnings
News Coverage
FOUR
Shift4 Payments
4.2613 of 5 stars
$69.64
+1.8%
$85.00
+22.1%
-2.7%$6.00B$2.56B49.043,030Analyst Upgrade
Analyst Revision
News Coverage
SPXC
SPX Technologies
2.9365 of 5 stars
$122.34
+0.9%
$130.00
+6.3%
+75.0%$5.66B$1.74B63.724,100Positive News
RCM
R1 RCM
4.6553 of 5 stars
$12.87
+0.8%
$17.00
+32.1%
-22.5%$5.41B$2.25B0.0030,000
KVYO
Klaviyo
1.9164 of 5 stars
$24.29
+1.0%
$37.60
+54.8%
N/A$6.35B$698.10M0.001,815Analyst Report
News Coverage

Related Companies and Tools

This page (NYSE:G) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners